Bleeding Disorders
Conference Coverage
Structured PPH management cuts severe hemorrhage
AUSTIN, TEX. – The checklist-driven approach yielded reductions in other morbidity surrogates as well.
Conference Coverage
Hydroxyurea in infancy yields better SCD outcomes
PITTSBURGH – Patients with SCD started on hydroxyurea before age 1 year had better lab and clinical results than did those started a few months...
From the Journals
Adding vasopressin in distributive shock may cut AF risk
Adding vasopressin cut risk of atrial fibrillation, compared with catecholamine vasopressors alone.
Conference Coverage
NHLBI seeks to accelerate hemostasis/thrombosis research
SAN DIEGO – About half of hemostasis/thrombosis research is basic in nature.
News
Single injection could treat hemophilia B long-term
Cell therapy could produce lasting effects in hemophilia B, according to a group of researchers. They genetically modified induced pluripotent...
News
PI3K inhibitors could treat HHT
Preclinical research suggests PI3K inhibitors could treat hereditary hemorrhagic telangiectasia (HHT). Experiments in mice and patient samples...
Conference Coverage
Consider caregiver oral health for children with bleeding disorders
SAN DIEGO – Ask parents if they’ve had a cavity in the last year.
News
Fostamatinib produces responses in ITP
Fostamatinib has produced “clinically meaningful” responses in adults with persistent or chronic immune thrombocytopenia (ITP), according to...
Conference Coverage
Time to scrap LMWH for prevention of placenta-mediated pregnancy complications?
SAN DIEGO – “It’s time to put the needles away for pregnant patients,” said Dr. Marc Rodger.
Conference Coverage
Experts offer guidance on use of emicizumab
SAN DIEGO – Emicizumab will likely provide a paradigm shift in managing hemophilia A with inhibitor antibodies.
News
FDA approves new drug for thrombocytopenia
The oral spleen tyrosine kinase inhibitor is expected to be available in the United States in late May.